Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Up 12.2% After Analyst Upgrade
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) shot up 12.2% during mid-day trading on Tuesday after JPMorgan Chase & Co. raised their price target on the stock from $32.00 to $36.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Day One Biopharmaceuticals traded as high as $17.39 and last […]
More Stories
Q2 Earnings Forecast for BBW Issued By DA Davidson
Build-A-Bear Workshop, Inc. (NYSE:BBW – Free Report) – Research analysts at DA Davidson issued their Q2 2026 earnings per share...
Compass Group PLC (OTCMKTS:CMPGY) Sees Significant Growth in Short Interest
Compass Group PLC (OTCMKTS:CMPGY – Get Free Report) saw a significant increase in short interest during the month of May....
Rafael (NYSE:RFL) Trading Up 2.6% – Still a Buy?
Rafael Holdings, Inc. (NYSE:RFL – Get Free Report)’s share price shot up 2.6% during trading on Monday . The stock...
Brokers Set Expectations for Alliant Energy FY2026 Earnings
Alliant Energy Co. (NASDAQ:LNT – Free Report) – Equities research analysts at Zacks Research lowered their FY2026 earnings per share...
Q2 EPS Estimates for AEO Decreased by Telsey Advisory Group
American Eagle Outfitters, Inc. (NYSE:AEO – Free Report) – Equities research analysts at Telsey Advisory Group reduced their Q2 2026...
The Goldman Sachs Group Reiterates “Neutral” Rating for Union Pacific (NYSE:UNP)
The Goldman Sachs Group reissued their neutral rating on shares of Union Pacific (NYSE:UNP – Free Report) in a research...